[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MA40596A - Combinaisons thérapeutiques d'un inhibiteur de btk et d'un inhibiteur de bcl-2 - Google Patents

Combinaisons thérapeutiques d'un inhibiteur de btk et d'un inhibiteur de bcl-2

Info

Publication number
MA40596A
MA40596A MA040596A MA40596A MA40596A MA 40596 A MA40596 A MA 40596A MA 040596 A MA040596 A MA 040596A MA 40596 A MA40596 A MA 40596A MA 40596 A MA40596 A MA 40596A
Authority
MA
Morocco
Prior art keywords
inhibitor
bcl
therapeutic combinations
btk
btk inhibitor
Prior art date
Application number
MA040596A
Other languages
English (en)
Other versions
MA40596B1 (fr
Inventor
Tjeerd Barf
Todd Covey
Ahmed Hamdy
Raquel Izumi
Dave Johnson
Allard Kaptein
Brian Lannutti
Wayne Rothbaum
roger Ulrich
Original Assignee
Acerta Pharma Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acerta Pharma Bv filed Critical Acerta Pharma Bv
Priority claimed from PCT/IB2015/056126 external-priority patent/WO2016024230A1/fr
Publication of MA40596A publication Critical patent/MA40596A/fr
Publication of MA40596B1 publication Critical patent/MA40596B1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4468Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA40596A 2014-08-11 2015-08-11 Combinaisons thérapeutiques d'un inhibiteur de btk et d'un inhibiteur de bcl-2 MA40596B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462035795P 2014-08-11 2014-08-11
PCT/IB2015/056126 WO2016024230A1 (fr) 2014-08-11 2015-08-11 Combinaisons thérapeutiques d'un inhibiteur de btk, d'un inhibiteur de pi3k, d'un inhibiteur de jak-2, et/ou d'un inhibiteur de bcl-2

Publications (2)

Publication Number Publication Date
MA40596A true MA40596A (fr) 2021-05-05
MA40596B1 MA40596B1 (fr) 2021-12-31

Family

ID=58699603

Family Applications (1)

Application Number Title Priority Date Filing Date
MA40596A MA40596B1 (fr) 2014-08-11 2015-08-11 Combinaisons thérapeutiques d'un inhibiteur de btk et d'un inhibiteur de bcl-2

Country Status (2)

Country Link
AR (1) AR101505A1 (fr)
MA (1) MA40596B1 (fr)

Also Published As

Publication number Publication date
AR101505A1 (es) 2016-12-21
MA40596B1 (fr) 2021-12-31

Similar Documents

Publication Publication Date Title
NO2022046I1 (no) Berotralstat and pharmaceutically acceptable salts thereof
HUE056329T2 (hu) BTK-inhibitor és BCL-2-inhibitor terápiás kombinációi
IL262387B (en) Arginase inhibitors and treatment applications thereof
DK3210977T3 (da) Hidtil ukendt aminoalkylbenzothiazepinderivat og anvendelse deraf
DK3155024T3 (da) Opholdsstrukturer og relaterede fremgangsmåder
MA49715A (fr) Oligomères et conjugués d'oligomères
DK2937422T3 (da) Fremgangsmåde og et kit til ikke-invasiv detektering af patogene genmutationer for fosterdøvhed
MA40933A (fr) Difluorométhyl-aminopyridines et difluorométhyl-aminopyrimidines
PT3747472T (pt) Combinações terapêuticas de um inibidor de cd19 e um inibidor de btk
DK3219089T3 (da) Træning i afgivelse af et lægemiddel
FR3019522B1 (fr) Ensemble sustentateur amovible d'un giravion et giravion
MA46783A (fr) Polythérapie de type thérapie cellulaire t et inhibiteur de btk
BR112016003413A2 (pt) prancha ergometrica de uma esteira ergometrica e esteira ergometrica
MA41794A (fr) Agents thérapeutiques modifiés et compositions associées
PL3240777T3 (pl) Inhibitory arginazy oraz ich zastosowania terapeutyczne
DK3142659T3 (da) Hiv-1 proteasehæmmere og anvendelser deraf
DK3231793T3 (da) Dihydropyromidin-2-on-forbindelser og medicinske anvendelser deraf
DK3240821T3 (da) Lavdosis gashydrathæmmersammensætning og tilhørende fremgangsmåde
DK3125874T3 (da) Et terapeutisk middel til anvendelse i behandlingen af infektioner
DK3137873T3 (da) Viscometer and methods of use thereof
DK3180335T3 (da) Cytokrom-p450-inhibitorer og anvendelser deraf
GB201418809D0 (en) Therapeutic agents and uses thereof
DK3229811T3 (da) Forebyggelse og behandling af betændelseslidelser
DK3215143T3 (da) Kombination omfattende spirulina og palmitoylethanolamid
MA40869A (fr) Combinaisons pharmaceutiques de vildagliptine et d'agonistes de ppar